Ethyl (3s,4aR,6S,8aR)-6-(4-ethoxycar-bonylimidazol-1-ylmethyl) decahydroiso-quinoline-3-carboxylic ester: A prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine

Sandra A. Filla, Mark A. Winter, Kirk W. Johnson, David Bleakman, Michael G. Bell, Thomas J. Bleisch, Ana M. Castaño, Amy Clemens-Smith, Miriam Del Prado, Donna K. Dieckman, Esteban Dominguez, Ana Escribano, Ken H. Ho, Kevin J. Hudziak, Mary A. Katofiasc, Jose A. Martinez-Perez, Ana Mateo, Brian M. Mathes, Edward L. Mattiuz, Ann Marie L. OgdenLee A. Phebus, Douglas R. Stack, Robert Stratford Jr., Paul L. Ornstein

Research output: Contribution to journalArticle

44 Citations (Scopus)

Abstract

Amino diacid 3, a highly selective competitive GluR5 kainate receptor antagonist, exhibited high GluR5 receptor affinity and selectivity over other glutamate receptors. Its diethyl ester prodrug 4 was orally active in two models of migraine: the neurogenic dural plasma protein extravasation model and the nucleus caudalis c-fos expression model. These data suggest that a GluR5 kainate receptor antagonist might be an efficacious antimigraine therapy with a novel mechanism of action.

Original languageEnglish (US)
Pages (from-to)4383-4386
Number of pages4
JournalJournal of Medicinal Chemistry
Volume45
Issue number20
DOIs
StatePublished - Sep 26 2002
Externally publishedYes

Fingerprint

Prodrugs
Migraine Disorders
Esters
Animal Models
Glutamate Receptors
Blood Proteins
quinoline
Gluk1 kainate receptor
Therapeutics

ASJC Scopus subject areas

  • Molecular Medicine
  • Drug Discovery

Cite this

Ethyl (3s,4aR,6S,8aR)-6-(4-ethoxycar-bonylimidazol-1-ylmethyl) decahydroiso-quinoline-3-carboxylic ester : A prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine. / Filla, Sandra A.; Winter, Mark A.; Johnson, Kirk W.; Bleakman, David; Bell, Michael G.; Bleisch, Thomas J.; Castaño, Ana M.; Clemens-Smith, Amy; Del Prado, Miriam; Dieckman, Donna K.; Dominguez, Esteban; Escribano, Ana; Ho, Ken H.; Hudziak, Kevin J.; Katofiasc, Mary A.; Martinez-Perez, Jose A.; Mateo, Ana; Mathes, Brian M.; Mattiuz, Edward L.; Ogden, Ann Marie L.; Phebus, Lee A.; Stack, Douglas R.; Stratford Jr., Robert; Ornstein, Paul L.

In: Journal of Medicinal Chemistry, Vol. 45, No. 20, 26.09.2002, p. 4383-4386.

Research output: Contribution to journalArticle

Filla, SA, Winter, MA, Johnson, KW, Bleakman, D, Bell, MG, Bleisch, TJ, Castaño, AM, Clemens-Smith, A, Del Prado, M, Dieckman, DK, Dominguez, E, Escribano, A, Ho, KH, Hudziak, KJ, Katofiasc, MA, Martinez-Perez, JA, Mateo, A, Mathes, BM, Mattiuz, EL, Ogden, AML, Phebus, LA, Stack, DR, Stratford Jr., R & Ornstein, PL 2002, 'Ethyl (3s,4aR,6S,8aR)-6-(4-ethoxycar-bonylimidazol-1-ylmethyl) decahydroiso-quinoline-3-carboxylic ester: A prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine', Journal of Medicinal Chemistry, vol. 45, no. 20, pp. 4383-4386. https://doi.org/10.1021/jm025548q
Filla, Sandra A. ; Winter, Mark A. ; Johnson, Kirk W. ; Bleakman, David ; Bell, Michael G. ; Bleisch, Thomas J. ; Castaño, Ana M. ; Clemens-Smith, Amy ; Del Prado, Miriam ; Dieckman, Donna K. ; Dominguez, Esteban ; Escribano, Ana ; Ho, Ken H. ; Hudziak, Kevin J. ; Katofiasc, Mary A. ; Martinez-Perez, Jose A. ; Mateo, Ana ; Mathes, Brian M. ; Mattiuz, Edward L. ; Ogden, Ann Marie L. ; Phebus, Lee A. ; Stack, Douglas R. ; Stratford Jr., Robert ; Ornstein, Paul L. / Ethyl (3s,4aR,6S,8aR)-6-(4-ethoxycar-bonylimidazol-1-ylmethyl) decahydroiso-quinoline-3-carboxylic ester : A prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine. In: Journal of Medicinal Chemistry. 2002 ; Vol. 45, No. 20. pp. 4383-4386.
@article{74c8a4306bd942169aa36caeaf2313b0,
title = "Ethyl (3s,4aR,6S,8aR)-6-(4-ethoxycar-bonylimidazol-1-ylmethyl) decahydroiso-quinoline-3-carboxylic ester: A prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine",
abstract = "Amino diacid 3, a highly selective competitive GluR5 kainate receptor antagonist, exhibited high GluR5 receptor affinity and selectivity over other glutamate receptors. Its diethyl ester prodrug 4 was orally active in two models of migraine: the neurogenic dural plasma protein extravasation model and the nucleus caudalis c-fos expression model. These data suggest that a GluR5 kainate receptor antagonist might be an efficacious antimigraine therapy with a novel mechanism of action.",
author = "Filla, {Sandra A.} and Winter, {Mark A.} and Johnson, {Kirk W.} and David Bleakman and Bell, {Michael G.} and Bleisch, {Thomas J.} and Casta{\~n}o, {Ana M.} and Amy Clemens-Smith and {Del Prado}, Miriam and Dieckman, {Donna K.} and Esteban Dominguez and Ana Escribano and Ho, {Ken H.} and Hudziak, {Kevin J.} and Katofiasc, {Mary A.} and Martinez-Perez, {Jose A.} and Ana Mateo and Mathes, {Brian M.} and Mattiuz, {Edward L.} and Ogden, {Ann Marie L.} and Phebus, {Lee A.} and Stack, {Douglas R.} and {Stratford Jr.}, Robert and Ornstein, {Paul L.}",
year = "2002",
month = "9",
day = "26",
doi = "10.1021/jm025548q",
language = "English (US)",
volume = "45",
pages = "4383--4386",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "20",

}

TY - JOUR

T1 - Ethyl (3s,4aR,6S,8aR)-6-(4-ethoxycar-bonylimidazol-1-ylmethyl) decahydroiso-quinoline-3-carboxylic ester

T2 - A prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraine

AU - Filla, Sandra A.

AU - Winter, Mark A.

AU - Johnson, Kirk W.

AU - Bleakman, David

AU - Bell, Michael G.

AU - Bleisch, Thomas J.

AU - Castaño, Ana M.

AU - Clemens-Smith, Amy

AU - Del Prado, Miriam

AU - Dieckman, Donna K.

AU - Dominguez, Esteban

AU - Escribano, Ana

AU - Ho, Ken H.

AU - Hudziak, Kevin J.

AU - Katofiasc, Mary A.

AU - Martinez-Perez, Jose A.

AU - Mateo, Ana

AU - Mathes, Brian M.

AU - Mattiuz, Edward L.

AU - Ogden, Ann Marie L.

AU - Phebus, Lee A.

AU - Stack, Douglas R.

AU - Stratford Jr., Robert

AU - Ornstein, Paul L.

PY - 2002/9/26

Y1 - 2002/9/26

N2 - Amino diacid 3, a highly selective competitive GluR5 kainate receptor antagonist, exhibited high GluR5 receptor affinity and selectivity over other glutamate receptors. Its diethyl ester prodrug 4 was orally active in two models of migraine: the neurogenic dural plasma protein extravasation model and the nucleus caudalis c-fos expression model. These data suggest that a GluR5 kainate receptor antagonist might be an efficacious antimigraine therapy with a novel mechanism of action.

AB - Amino diacid 3, a highly selective competitive GluR5 kainate receptor antagonist, exhibited high GluR5 receptor affinity and selectivity over other glutamate receptors. Its diethyl ester prodrug 4 was orally active in two models of migraine: the neurogenic dural plasma protein extravasation model and the nucleus caudalis c-fos expression model. These data suggest that a GluR5 kainate receptor antagonist might be an efficacious antimigraine therapy with a novel mechanism of action.

UR - http://www.scopus.com/inward/record.url?scp=0037179709&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037179709&partnerID=8YFLogxK

U2 - 10.1021/jm025548q

DO - 10.1021/jm025548q

M3 - Article

C2 - 12238915

AN - SCOPUS:0037179709

VL - 45

SP - 4383

EP - 4386

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 20

ER -